Medigent being a growing organization is making its place in the world of real world evidence (RWE). We are collaborating with clients to provide real world evidence solutions (RWES) that can support the pharmaceutical products throughout their life cycle. Our service spectrum in RWES includes:

• Health Economics and Outcomes Research (HEOR): Includes pharmacoeconomic modelling like budget impact models, cost effectiveness, cost minimization and cost utility analysis, dynamic disease modelling, patient reported outcomes (PROs) and preparing HEOR reports for publications, insurance payers, pharma companies, and other healthcare providers.
• Systematic Reviews and Meta-analysis: Conducting systematic reviews and meta-analysis, starting from defining the scope of the work to building search strategies, data extraction, data analysis, and ultimately deriving outcomes for clinical and economic analysis.
• Data Collection and Analysis: Data collection from observational studies, registries, retrospective studies, or epidemiological studies, its data analysis, report writing and publications.
• Market Access Documents: Global Value Dossiers, pricing and reimbursement, KOL mapping, health technology assessment (HTA), critical appraisals and value communications